| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &CEO
1 company
Egholm Michael is a President &CEO at LAB. Recent filings cover 0 purchases and 3 sales. Those positions are worth an estimated $5.0M at current prices.
Our model assigns Egholm Michael a below-average insider score of 33/100, based on 3 past trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -6.6%.
Egholm Michael's largest disclosed position is in LAB as President &CEO, worth about $5.0M. The recent filings there lean toward selling, a net 15,308 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 23, 2025 | LAB Standard Biotools Inc. | President &CEO | Sell | 5,473 | $0.94 | $5,150.09 | -0.2% | +30.2% | +11.8% | |
| May 22, 2025 | LAB Standard Biotools Inc. | President &CEO | Sell | 5,116 | $1.00 | $5,126.23 | -0.2% | +28.9% | +7.9% | |
| May 21, 2025 | LAB Standard Biotools Inc. | President &CEO | Sell | 4,719 | $1.03 | $4,860.57 | -0.2% | +22.1% | -0.0% |